Phase Ib Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy for High-risk Diffuse Large B-cell Lymphoma
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2018
At a glance
- Drugs Roflumilast (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 14 Jun 2018 Status changed from not yet recruiting to recruiting.
- 14 May 2018 Planned initiation date changed from 30 Apr 2018 to 31 May 2018.
- 13 Mar 2018 New trial record